Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
1.
The Journal of the Korean Bone and Joint Tumor Society ; : 45-49, 2012.
Article in Korean | WPRIM | ID: wpr-150789

ABSTRACT

Skip lesion is not uncommon feature in osteosarcoma and considered to be importantly associated with poor prognosis factor, and thus, should be excised with the main mass. The accurate pre-operative evaluation of the intramedullary extent of osteosarcoma is essential, because it determines the level of bone resection. Among the reliable detection methods, bone scan has a drawback of high rate of false negative results and regional MRI has a difficulty to cover the whole involved lesions without clinical suspicion. The authors report a case of osteosarcoma of the distal femur with a proximal skip lesion that was not detected by either regional MR imaging or by bone scan, but which was visualized by FDG-PET/CT.


Subject(s)
Complement System Proteins , Femur , Neoplasm Metastasis , Osteosarcoma , Prognosis
2.
Nuclear Medicine and Molecular Imaging ; : 421-428, 2009.
Article in Korean | WPRIM | ID: wpr-190758

ABSTRACT

PURPOSE: We have evaluated characteristics of adrenal masses incidentally observed in nonenhanced F-18 FDG PET/CT of the oncologic patients and the diagnostic ability of F-18 FDG PET/CT to differentiate malignant from benign adrenal masses. MATERIALS AND METHODS: Between Mar 2005 and Aug 2008, 75 oncologic patients (46 men, 29 women; mean age, 60.8+/-10.2 years; range, 35-87 years) with 89 adrenal masses incidentally found in PET/CT were enrolled in this study. For quantitative analysis, size (cm), Hounsfield unit (HU), maximum standardized uptake value (SUVmax), SUVratio of all 89 adrenal masses were measured. SUVmax of the adrenal mass divided by SUVliver, which is SUVmax of the segment 8, was defined as SUVratio. The final diagnosis of adrenal masses was based on pathologic confirmation, radiologic evaluation (HU<0 : benign), and clinical decision. RESULTS: Size, HU, SUVmax, and SUVratio were all significantly different between benign and malignant adrenal masses.(P < 0.05) And, SUVratio was the most accurate parameter. A cut-off value of 1.0 for SUVratio provided 90.9% sensitivity and 75.6% specificity. In small adrenal masses (1.5 cm or less), only SUVratio had statistically significant difference between benign and malignant adrenal masses. Similarly a cut-off value of 1.0 for SUVratio provided 80.0% sensitivity and 86.4% specificity. CONCLUSION: F-18 FDG PET/CT can offer more accurate information with quantitative analysis in differentiating malignant from benign adrenal masses incidentally observed in oncologic patients, compared to nonenhanced CT.


Subject(s)
Humans , Male , Adrenal Gland Neoplasms , Diagnosis, Differential , Neoplasm Metastasis , Sensitivity and Specificity
3.
Journal of Breast Cancer ; : 309-315, 2009.
Article in Korean | WPRIM | ID: wpr-101498

ABSTRACT

PURPOSE: This study was to investigate the clinical significance of diffusely increased F-18 FDG uptake in the thyroid gland as an incidental finding on F-18 FDG PET/CT imaging in patients with breast carcinoma. METHODS: One hundred four patients with breast carcinoma who had no prior history of thyroid disease were enrolled. All patients underwent F-18 FDG PET/CT, ultrasound and thyroid function test (TFT-TSH, FT4, and T3), anti-TPO antibody test within 2 weeks. Also we checked estrogen (ER) and progesterone receptors (PR). We classified all patients into subgroups according to the existence and degree of F-18 FDG uptake in the thyroid gland, and evaluated the difference between subgroups. RESULTS: Of the 104 patients, 42 (40.4%) subjects showed diffusely increased thyroid uptakes. There was no significant difference in rate of abnormality in TFT and thyroid US, and existence of anti-TPO antibody and ER/PR between two groups. Of 42 patient who showed diffuse uptake, 12 (28.5%), 13 (31.0%), and 17 (40.5%) subjects demonstrated hypointense, isointense, and hyperintense thyroid uptake compared with activity of mediastinal blood pool. Thirteen (76.4%) of 17 subjects in the hyperintense thyroid uptake group revealed abnormality in various tests (US, TFT, and anti-TPO antibody). The rate of abnormality in this group was significantly different with the other two groups (p=0.002). CONCLUSION: Our data suggested that the rate of diffuse thyroid uptakes on F-18 FDG PET/CT imaging of patients with breast carcinoma was higher than healthy subjects. In case of someone who had no prior thyroid disease showed diffuse thyroid uptakes more than activity of mediastinal blood pool on F-18 FDG PET/CT imaging, it should be considered further evaluation about the thyroid gland.


Subject(s)
Humans , Breast , Breast Neoplasms , Estrogens , Incidental Findings , Receptors, Progesterone , Thyroid Diseases , Thyroid Function Tests , Thyroid Gland
4.
Nuclear Medicine and Molecular Imaging ; : 120-128, 2009.
Article in Korean | WPRIM | ID: wpr-29288

ABSTRACT

PURPOSE: Early detection of recurrence is an important factor for long term survival of patients with colorectal cancer. Measurement of serum levels of CEA, CA 19-9, CT and PET/CT has been commonly used in the postoperative surveillance of colorectal cancer. The purpose of this study was to compare the diagnostic ability of PET/CT, tumor marker and CT for recurrence in colorectal cancer patients after treatment. MATERIALS AND METHODS: F-18 FDG PET/CT imaging was performed in 189 colorectal cancer patients who underwent curative surgical resection and/or chemotherapy. Measurement of serum levels of CEA, CA 19-9 and CT imaging were performed within 2 months of PET/CT examination. Final diagnosis of recurrence was made by biopsy, radiologic studies or clinical follow-up for 6 months after each study. RESULTS: Overall sensitivity, specificity of PET/CT was 94.7%, 91.1%, while those of serum CEA were 44.7% and 97.3%, respectively. Sensitivity and specificity were 94.2%, 90.4% for PET/CT and better than those of combined CEA and CA 19-9 measurement (52.1%, 88.5%) in 174 patients measured available both CEA and CA 19-9 data. In 115 patients with both tumor markers and CT images available, PET/CT showed similar sensitivity but higher specificity (92.9%, 91.3%) compared to combination of tumor markers and CT images (92.9%, 74.1%). CONCLUSION: PET/CT was superior for detection of recurred colorectal cancer patients compared with both CEA, CA 19-9, and even with combination of both tumor markers and CT. Therefore PET/CT could be used as a routine surveillance examination to detect recurrence or metastasis of colorectal cancer.


Subject(s)
Humans , Biopsy , Carcinoembryonic Antigen , Colorectal Neoplasms , Follow-Up Studies , Neoplasm Metastasis , Recurrence , Sensitivity and Specificity , Biomarkers, Tumor
5.
Nuclear Medicine and Molecular Imaging ; : 499-504, 2009.
Article in Korean | WPRIM | ID: wpr-155607

ABSTRACT

F-18 fluorodeoxyglucose positron emission tomography (F-18 FDG PET/CT) plays an important role in diagnosis of malignant tumors and adds to conventional imaging in the staging of pertoneal carcinomatosis. However, false positive cases resulting from benign disease such as tuberculosis may occur. We report two cases of peritoneal tuberculosis on F-18 FDG PET/CT which showed multiple hypermetabolic foci in the mesentery and peritoneum with increased serum cancer antigen 125 (CA 125). Subsequent F-18 FDG PET/CT showed a disappearance of pathologic uptake following treatment with anti-tuberculosis drugs.


Subject(s)
Carcinoma , Mesentery , Peritoneum , Peritonitis, Tuberculous , Positron-Emission Tomography , Tuberculosis
6.
Nuclear Medicine and Molecular Imaging ; : 577-581, 2009.
Article in Korean | WPRIM | ID: wpr-198896

ABSTRACT

Solid pseudo-papillary tumor (SPT) is a rare pancreatic neoplasm with low malignant potential, which tends to occur predominantly in younger females. Only a few cases of SPT seen on F-18 FDG PET scan have been reported, and the findings are not fully evaluated. A 33 year-old woman underwent F-18 FDG PET/CT study for staging of renal cell carcinoma. She was diagnosed with SPT of the pancreas 6 years ago, and has not had any treatment so far. Recent PET/CT showed marked F-18 FDG uptake in the peripheral solid portion and relatively less F-18 FDG uptake to the central calcified portion of SPT. We report one case of SPT of the pancreas on F-18 FDG PET/CT.


Subject(s)
Female , Humans , Carcinoma, Renal Cell , Pancreas , Pancreatic Neoplasms , Positron-Emission Tomography
7.
Nuclear Medicine and Molecular Imaging ; : 333-336, 2008.
Article in English | WPRIM | ID: wpr-227105

ABSTRACT

A 52-year-old woman with a history of general weakness, fatigue, weight loss, elevated serum levels of liver transaminase enzyme for three months underwent an F-18 FDG PET/CT scan to evaluate a cause of the hepatosplenomegaly found on abdominal ultrasonography. Initial PET/CT revealed markedly enlarged liver and spleen with intense FDG uptake. Otherwise, there were no areas of abnormal FDG uptake in whole body image. Histological evaluation by a hepatic needle biopsy demonstrated diffuse large B cell type lymphoma and final diagnosis for this patient was hepatosplenic B-cell lymphoma. She received five cycles of CHOP chemotherapy, and second PET/CT scan was followed after then. Follow-up PET-CT revealed normal sized liver with disappearance of abnormal FDG uptake. Hepatosplenic B-cell lymphoma is relatively rare and mostly presents as single or multiple nodules.1,2 Diffuse type hepatosplenic lymphoma is extremely rare and poorly recognized entity.3 The diagnosis is very difficult and complicated by the presence of misleading symptoms.4 In this rare hepatosplenic B-cell lymphoma case, F-18 FDG PET/CT scan provided a initial diagnostic clue of hepatosplenic lymphoma and an accurate chemotherapy response.


Subject(s)
Female , Humans , Middle Aged , B-Lymphocytes , Biopsy, Needle , Body Image , Fatigue , Follow-Up Studies , Hepatomegaly , Liver , Lymphoma , Lymphoma, B-Cell , Spleen , Weight Loss
8.
Nuclear Medicine and Molecular Imaging ; : 414-418, 2008.
Article in Korean | WPRIM | ID: wpr-222902

ABSTRACT

The role of positron emission tomography (PET) with F-18 fluorodeoxyglucose (F-18 FDG) in the diagnosis of hepatocellulcar carcinoma (HCC) has been limited because of a variable FDG uptake in HCC. However, the usefulness of PET/CT for detecting extrahepatic metastasis and monitoring of the treatment response in HCC has been reported. A 55-year-old man with a hepatitis B surface antigen-positive, was admitted to our hospital due to dyspnea, general weakness and body weight loss for one month. Chest X-ray showed multiple reticulo-nodular densities on both lower lung fields, which implies metastatic lesions. F-18 FDG PET/CT revealed consecutively intense hypermetabolic mass in right hepatic lobe, inferior vena cava and right atrium. We report a case of HCC with IVC and right atrium invasion identified by F-18 FDG PET/CT.


Subject(s)
Humans , Middle Aged , Body Weight , Carcinoma, Hepatocellular , Dyspnea , Heart Atria , Hepatitis B , Lung , Neoplasm Metastasis , Positron-Emission Tomography , Thorax , Vena Cava, Inferior
9.
Nuclear Medicine and Molecular Imaging ; : 247-251, 2007.
Article in Korean | WPRIM | ID: wpr-162719

ABSTRACT

A 38-year-old man who was diagnosed with malignant paraganglioma underwent computed tomography (CT) and I-131 metaiodobenzylguanidine (MIBG) san. CT showed extensive lymph node enlargement in right iliac area and retroperitoneum with severe hydronephrosis and mass on posterior bladder wall. However, I-131 MIBG scan didn't showed abnormal uptake. He also underwent F-18 fluorodeoxyglucose (FDG) positron emisson tomography/CT for localizing accurate tumor site. F-18 FDG PET/CT showed multiple metastases of left supraclavicular, hilar, mediastinal para-aortic, inguinal, right iliac lymph nodes, lung, vertebrae, and pelvis. There are a few reports showing that the F-18 FDG PET/CT is helpful for staging and localizing tumor site of patients who are diagnosed with negative on the MIBG scans. Thus, we report a case with paraganglioma which showed negative I-131 MIBG scan, but revealed multiple intense hypermetabolic foci in F-18 FDG PET/CT.


Subject(s)
Adult , Humans , 3-Iodobenzylguanidine , Electrons , Hydronephrosis , Lung , Lymph Nodes , Neoplasm Metastasis , Paraganglioma , Pelvis , Positron Emission Tomography Computed Tomography , Spine , Urinary Bladder
10.
Nuclear Medicine and Molecular Imaging ; : 141-147, 2006.
Article in Korean | WPRIM | ID: wpr-14048

ABSTRACT

PET detects only less than 50% of early gastric cancer and 62-98% of advanced gastric cancer. Therefore, mass screening programs are recommended for all adults over the age of 40 for early detection and early treatment of gastric cancer through endoscopy or various radiological tests. The most important step after being diagnosed with gastric cancer is accurate staging, which mainly evaluates tumor resectability to avoid unnecessary surgery. Important factors that affect tumor resectability are whether the tumor can be separated from adjacent organs or important blood vessels, the extent of lymph node metastasis, presence of peritoneal metastasis, or distant organ metastasis. To evaluate the extent of local tumor invasion, anatomical imaging that has superior spatial resolution is essential. There are a few studies on prognostic significance of FDG uptake with inconsistent results between them. In spite of lower sensitivities for lymph node staging, the specificities of CT and PET are very high, and the specificity for PET tends to be higher than that for CT. Limited data published so far show that PET seems less useful in the detection of lung and bone metastasis. In the evaluation of pleural or peritoneal metastasis, PET seems very specific but insensitive as well. When FDG uptake of the primary tumor is low, the distant metastasis is also known to show low FDG uptake reducing its detection. There are only a few data available in the evaluation of recurrence detection and treatment response using FDG PET.


Subject(s)
Adult , Humans , Blood Vessels , Endoscopy , Lung , Lymph Nodes , Mass Screening , Neoplasm Metastasis , Positron Emission Tomography Computed Tomography , Recurrence , Sensitivity and Specificity , Stomach Neoplasms , Unnecessary Procedures
11.
Journal of Korean Society of Spine Surgery ; : 191-199, 2006.
Article in Korean | WPRIM | ID: wpr-152050

ABSTRACT

STUDY DESIGN: A prospective study of the reproducibility of F-18 FDG-PET. OBJECTIVES: The purpose of this study was to determine whether F-18 FDG-PET had value in distinguishing between vertebral pathologic fractures and osteoporotic compression fractures. SUMMARY OF LITERATURE REVIEW: There were many reports in the literature about vertebral pathologic disease studied with F-18 FDG-PET, but few about the distinction between pathologic and benign causes in fractured vertebrae. MATERIALS AND METHODS: Twenty-nine patients with vertebral fractures that did not result from major trauma, who were admitted to our hospital from December 2002 to May 2004, were included in this study; and all of them were evaluated with MRI and F-18 FDG-PET. Their final diagnoses were confirmed by biopsy (n=12) or clinical follow-up (n=17). There were 18 cases of vertebral compression fractures, 11 cases of pathologic fractures (4 cases of tumor lesions and 7 cases of pyogenic spondylitis). F-18 FDG-PET images of those patients were interpreted as vertebral compression fractures or pathologic fractures by one nuclear medicine specialist and one radiology specialist without any clinical or radiologic information. The sensitivity and specificity of MRI and F-18 FDG-PET for the diagnosis of vertebral pathologic fractures were calculated and compared. RESULTS: Twenty-four (82.8 %) of 29 cases demonstrated a coincidence between MRI and F-18 FDG-PET interpretations. The sensitivity of F-18 FDG-PET for the diagnosis of vertebral pathologic fractures was 90.9 % and the specificity was 88.9 %. The sensitivity of MRI was 81.8% and the specificity was 83.3%. F-18 FDG-PET demonstrated a higher sensitivity and specificity, and these were statistically insignificant differences. CONCLUSIONS: F-18 FDG-PET is a useful method for determining the differential diagnosis of vertebral pathologic fractures, with high sensitivity and specificity.


Subject(s)
Humans , Biopsy , Diagnosis , Diagnosis, Differential , Follow-Up Studies , Fractures, Compression , Fractures, Spontaneous , Magnetic Resonance Imaging , Nuclear Medicine , Prospective Studies , Sensitivity and Specificity , Specialization , Spine
12.
Journal of the Korean Gastric Cancer Association ; : 291-294, 2006.
Article in Korean | WPRIM | ID: wpr-37463

ABSTRACT

F-18 FDG-PET/CT could be used to evaluate the surveillance of recurrent stomach cancer, but some cases reported as false-positives. The authors found an activated charcoal granuloma from intraperitoneal chemotherapy by using a curative resection and mitomycin C for stomach cancer. A mass behind the right colon that showed on CT 6 months after an operation in a 46-year-old male patient had no progression in size, but 36 months after the operation, an increase was seen on F-18 FDG-PET/CT, and a metastatic tumor was suspected. The tumor was resected by an explorative laparotomy and was diagnosed as being an activated charcoal granuloma based on the histologic finding. Based on this case, we should be reminded of the possibility of a false-positive on analysis of F-18 FDG-PET/CT caused by an activated charcoal granuloma in a patient who has intraperitoneal chemotherapy.


Subject(s)
Humans , Male , Middle Aged , Charcoal , Colon , Drug Therapy , Granuloma , Laparotomy , Mitomycin , Stomach Neoplasms
13.
Nuclear Medicine and Molecular Imaging ; : 271-274, 2006.
Article in English | WPRIM | ID: wpr-37106

ABSTRACT

We report the case of a 64-year-old man with superior vena cava (SVC) syndrome due to tumor thrombus from recurrent hepatocellular carcinoma (HCC). He presented with new onset of facial swelling for 10 days. HCC was detected ten years ago. He has undergone repeated transcatheter arterial embolization (TAE) and chemotherapy. Chest computed tomography (CT) demonstrated tumor thrombus in the SVC extending to right atrium. He underwent whole body F-18 fluorodeoxyglucose(FDG) positron emission tomography/computed tomography (PET/CT) scanning for assessing the effect of TAE in HCC. F-18 FDG PET/CT showed increased uptake in the residual liver mass indicating viable tumor. There was another intense F-18 FDG accumulation in SVC extending to right atrium to suggest tumor thrombus. This case illustrates that F-18 FDG PET/CT is useful to identification of distant metastases as well as assessment of response to therapy in long-term survival HCC patients.


Subject(s)
Humans , Middle Aged , Carcinoma, Hepatocellular , Drug Therapy , Electrons , Heart Atria , Liver , Neoplasm Metastasis , Positron Emission Tomography Computed Tomography , Superior Vena Cava Syndrome , Thorax , Thrombosis , Vena Cava, Superior
14.
Nuclear Medicine and Molecular Imaging ; : 275-278, 2006.
Article in English | WPRIM | ID: wpr-37105

ABSTRACT

We report the case of a 73-year-old man who had prostate cancer with bone metastases. Tc-99m HDP Whole body bone scan revealed multiple areas of increased bony uptake consistent with widespread bone metastases. F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) demonstrated mild F-18 FDG uptake in the lymph nodes of neck, abdomen, and pelvis. However, abnormal F-18 FDG uptake was not seen in the skeletal system. Biopsy and immunohistochemical stains of left supraclavicular mass showed metastatic prostate adenocarcinoma. Currently, there are a few reported cases of F-18 FDG PET/CT evaluation of bone metastases in prostate cancer. We discuss the discrepancy between F-18 FDG PET/CT and bone scan in the detection of osseous metastases of prostate cancer.


Subject(s)
Aged , Humans , Abdomen , Adenocarcinoma , Biopsy , Coloring Agents , Electrons , Lymph Nodes , Neck , Neoplasm Metastasis , Pelvis , Positron Emission Tomography Computed Tomography , Prostate , Prostatic Neoplasms
15.
The Korean Journal of Gastroenterology ; : 378-387, 2006.
Article in Korean | WPRIM | ID: wpr-227977

ABSTRACT

18F-FDG PET scan is an useful functional whole body imaging modality that images various types of malignancies with relative high sensitivity and specificity in a reasonably rapid time. It depicts a lesion based on abnormal glucose metabolism whereas CT detects malignant process mostly based on altered anatomy. In patients with gastric cancers, PET scan detects only less than 50% of early cancers and 62-98% of advanced cancers. For initial T staging, anatomical imaging with a high spatial resolution is essential. There are a few studies on the prognostic significance of FDG uptake with inconsistent results. In spite of low sensitivity for lymph node staging, the specificity of CT and PET scan are very high, and the specificity of PET scan tends to be higher than that of CT. Detection of distant metastases on PET scan is dependent on tumor histology, degree of FDG uptake in primary tumors, sites of distant metastases, etc. There are only a few data available for the evaluation of recurrence detection and treatment responses using FDG PET scan. FDG PET scan has been used in the preoperative staging of colorectal cancer with some promising results. It seems to be the most useful in restaging recurrent tumors and selecting those patients who would benefit from surgery. PET scan has a potential value in assessing treatment responses after various combination of treatments in patients with colorectal cancer.


Subject(s)
Humans , Fluorodeoxyglucose F18 , Gastrointestinal Neoplasms/pathology , Neoplasm Staging , Positron-Emission Tomography , Radiopharmaceuticals , Tomography, X-Ray Computed
16.
Korean Journal of Nuclear Medicine ; : 269-277, 2005.
Article in Korean | WPRIM | ID: wpr-145410

ABSTRACT

PURPOSE: This study evaluated the diagnostic value of 18F-FDG PET/CT in detecting cervical lymph node metastases in head and neck cancer patients. MATERIALS AND METHODS: The patients were divided into two groups, 46 patients underwent PET/CT scan for initial staging before surgery, and 20 patients for restaging of recurrence after primary treatment. Increased FDG uptakes in cervical lymph nodes were evaluated retrospectively and correlated with the histopathologic results. RESULTS: In the initial staging group, 21 lymph nodes were detected by PET/CT in 15 patients. 20 lymph nodes were confirmed as metastases with a mean peak SUV of 5.84, and the remaining one lymph node was an inflammatory lesion, with a peak SUV of 2.75. Seven metastatic lymph nodes were reported only by histopathology. The sensitivity, specificity, positive predictive value and negative predictive value were 74.0%, 99.6%, 95.2% and 97.3%, respectively. In the recurrence group, 11 lymph nodes were detected in 9 patients, and 8 nodes were true positive, with a mean peak SUV of 5.65. The other three were inflammatous lymph nodes, and the peak SUVs were 2.16, 2.94 and 3.53. One false negative lymph node was reported. The sensitivity, specificity, positive predictive value and negative predictive value were 88.8%, 97.7%, 72.7% and 92.9%, respectively. CONCLUSIONS: FDG-PET/CT shows higher positive predictive value in the initial staging group, and better sensitivity in the recurrence group. Therefore PET/CT could be useful for both initial staging and restaging of recurrent cervical lymph node metastases.


Subject(s)
Humans , Diagnosis , Fluorodeoxyglucose F18 , Head and Neck Neoplasms , Head , Lymph Nodes , Neoplasm Metastasis , Positron Emission Tomography Computed Tomography , Recurrence , Retrospective Studies , Sensitivity and Specificity
17.
Korean Journal of Nuclear Medicine ; : 15-20, 2005.
Article in Korean | WPRIM | ID: wpr-182290

ABSTRACT

PURPOSE: Physiologic intestinal FDG uptake is frequently observed in asymptomatic individuals for cancer screening FDG PET. Colonic FDG accumulation is a well-known confusing findings that interfere true cancer detection or cause false positive. The aim of this study was to evaluate the pattern and intensity of colonic uptake in whole body FDG PET in asymptomatic healthy adults and to correlate them with colonoscopic findings. MATERIALS AND METHODS: We reviewed retrospectively 64 subjects (age: 27-87, M: F = 31: 33 ) who underwent both FDG PET and colonoscopy for cancer screening. FDG uptake patterns were classified as focal, segmental and diffuse. Maximum SUV were measured. The PET results were compared with colonoscopic and histologic findings. RESULTS: In 13 patients FDG bowel uptake was interpreted as focal, in 17 patients as segmental and in 34 patients as diffuse uptake. Six adenomas (17.6%, average diameter =5.0 mm) were found in diffuse pattern, 7 adenomas (41.1%, 5.6 mm) in segmental and 4 adenomas and 1 adenocarcinoma (38.5%, 16.4 mm) in focal uptake pattern. In patients with focal uptake, four were non-adenomatous pathologic lesions (30.8%, 2 intestinal tuberculosis, 2 mucosal ulcer). There is no difference of mean SUV between patients with adenoma and with negative colonoscopic results in each group of intestinal FDG pattern (Diffuse: 1.7 +/- 0.1 vs. 1.9 +/- 0.5, Segmental: 4.8 +/- 3.6 vs. 4.2 +/- 1.2, Focal: 6.5 +/- 4.7 vs. 3.5 +/- 1.3). Large adenomas (> 1 cm) can be detected more in the focal uptake pattern (4 out of 5) rather than in segmental (1 out of 7) or diffuse uptake (none) and had higher SUV (6.3 +/- 4.8) than small adenomas (3.5 +/- 3.0) (statistically insignificant). CONCLUSION: Focal FDG uptake is associated more often with large adenoma and other pathologic findings in colonoscopy. Segmental uptake cannot discriminate presence of adenoma from negative results, while diffuse pattern may have more chance to be normal.


Subject(s)
Adult , Humans , Adenocarcinoma , Adenoma , Colon , Colonoscopy , Early Detection of Cancer , Retrospective Studies , Tuberculosis
18.
Korean Journal of Nuclear Medicine ; : 239-245, 2005.
Article in Korean | WPRIM | ID: wpr-115918

ABSTRACT

PURPOSE: Hypereosinophilic syndrome (HES) is an infiltrative disease of eosinophils affecting multiple organs including the lung. F-18 2-fluoro-2-deoxyglucose (F-18 FDG) may accumulate at sites of inflammation or infection, making interpretation of whole body PET scan difficult in patients with cancer. This study was to evaluate the PET findings of HES with lung involvement and to find out differential PET features between lung malignancy and HES with lung involvement. MATERIAL AND METHODS: F-18 FDG PET and low dose chest CT scan was performed for screening of lung cancer. Eight patients who showed ground-glass attenuation (GGA) and consolidation on chest CT scan with peripheral blood eosinophilia were included in this study. The patients with history of parasite infection, allergy and collagen vascular disease were excluded. CT features and FDG PET findings were meticulously evaluated for the distribution of GGA and consolidation and nodules on CT scan and mean and maximal SUV of abnormalities depicted on F-18 FDG PET scan. In eight patients, follow-up chest CT scan and FDG PET scan were done one or two weeks after initial study. RESULTS: F-18 FDG PET scan identified metabolically active lesions in seven out of eight patients. Maximal SUV was ranged from 2.8 to 10.6 and mean SUV was ranged from 2.2 to 7.2. Remaining one patient had maximal SUV of 1.3. On follow-up FDG PET scan taken on from one to four weeks later showed decreased degree of initially noted FDG uptakes or migration of previously noted abnormal FDG uptakes. CONCLUSIONS: Lung involvement in the HES might be identified as abnormal uptake foci on FDG PET scan mimicking lung cancer. Follow-up FDG PET and CT scan for the identification of migration or resolution of abnormalities and decrement of SUV would be of help for the differentiation between lung cancer and HES with lung involvement.


Subject(s)
Humans , Collagen , Eosinophilia , Eosinophils , Fluorodeoxyglucose F18 , Follow-Up Studies , Hypereosinophilic Syndrome , Hypersensitivity , Inflammation , Lung , Lung Neoplasms , Mass Screening , Parasites , Positron-Emission Tomography , Tomography, X-Ray Computed , Vascular Diseases
19.
Korean Journal of Nuclear Medicine ; : 233-240, 2004.
Article in Korean | WPRIM | ID: wpr-52730

ABSTRACT

PURPOSE: We developed a computer-aided classifier using artificial neural network (ANN) to discriminate the cerebral metabolic pattern of medial and lateral temporal lobe epilepsy (TLE). Materials and METHODS: We studied brain F-18-FDG PET images of 113 epilepsy patients sugically and pathologically proven as medial TLE (left 41, right 42) or lateral TLE (left 14, right 16). PET images were spatially transformed onto a standard template and normalized to the mean counts of cortical regions. Asymmetry indices for predefined 17 mirrored regions to hemispheric midline and those for medial and lateral temporal lobes were used as input features for ANN. ANN classifier was composed of 3 independent multi-layered perceptrons (1 for left/right lateralization and 2 for medial/lateral discrimination) and trained to interpret metabolic patterns and produce one of 4 diagnoses (L/R medial TLE or L/R lateral TLE). Randomly selected 8 images from each group were used to train the ANN classifier and remaining 81 images were used as test sets. The accuracy of the diagnosis with ANN was estimated by averaging the agreement rates of independent 50 trials and compared to that of nuclear medicine experts. RESULTS: The accuracy in lateralization was 89% by the human experts and 90% by the ANN classifier. Overall accuracy in localization of epileptogenic zones by the ANN classifier was 69%, which was comparable to that by the human experts (72%). CONCLUSION: We conclude that ANN classifier performed as well as human experts and could be potentially useful supporting tool for the differential diagnosis of TLE.


Subject(s)
Humans , Artificial Intelligence , Brain , Diagnosis , Diagnosis, Differential , Discrimination, Psychological , Epilepsy , Epilepsy, Temporal Lobe , Neural Networks, Computer , Nuclear Medicine , Temporal Lobe
20.
Rev. chil. radiol ; 8(2): 63-69, 2002. ilus
Article in Spanish | LILACS | ID: lil-627477

ABSTRACT

Functional brain imaging with PET and SPECT have a definitive and well established role in the investigation of a variety of conditions such as dementia, epilepsy and drug addiction. With these methods it is possible to detect early rCBF (regional Cerebral Blood Flow) changes seen in dementia (even before clinical symptoms) and differentiate Alzheimer's disease from other dementias by means of the rCBF pattern change. 18-F-FDG PET imaging is a useful tool in partial epilepsy because both rCBF and brain metabolism are compromised at the epileptogenic focus. During the seizure, rCBF dramatically increases locally. Using SPECT it is possible to locate such foci with 97% accuracy. In drug addiction, particularly with cocaine, functional imaging has proven to be very sensitive to detect brain flow and metabolism derangement early in the course of this condition. These findings are important in many ways: prognostic value, they are used as a powerful reinforcement tool and to monitor functional recovery with rehabilitation. There are many other conditions in which functional brain imaging is of importance such as acute stroke treatment assessment, trauma rehabilitation and in psychiatric and abnormal movement diseases specially with the development of receptor imaging.


Existen numerosas indicaciones claramente establecidas para el uso del SPECT y PET en patología neuro-psiquiátrica, particularmente en el estudio de demencias, epilepsia y adicción a drogas. Estos métodos permiten detectar precozmente (aun antes de las manifestaciones clínicas) cambios en la perfusión y metabolismo cerebral en pacientes con demencias. Es posible además diferenciar la enfermedad de Alzheimer de otras causas de demencia, analizando el patrón de la alteración neuro- funcional. En epilepsia parcial, tanto el metabolismo como la perfusión están alterados en el foco epileptogénico, lo que puede ser detectado con F-18FDG PET. Durante la crisis epiléptica, el flujo sanguíneo puede aumentar dramáticamente en el foco epileptogénico, lo que puede ser detectado con SPECT con 97% de certeza. En pacientes drogadictos, especialmente a la cocaína, estos métodos han demostrado ser muy sensibles para la detección precoz de cambios en el flujo y metabolismo cerebral, lo que es clínicamente importante en varios aspectos: 1) Tiene valor pronóstico (neuro-funcional), 2) Se puede usar para aumentar la adherencia a la terapia y 3) Permite evaluar objetivamente la recuperación funcional. Existen muchas otras indicaciones presentes y futuras, por ejemplo: en la monitorización de la revascularización en accidentes vasculares cerebrales agudos, rehabilitación post TEC, estudio de patología psiquiátrica y movimientos anormales especialmente con el desarrollo de radioligandos.


Subject(s)
Humans , Tomography, Emission-Computed, Single-Photon/methods , Positron-Emission Tomography/methods , Neuropsychiatry , Parkinson Disease/diagnostic imaging , Epilepsy/diagnostic imaging , Alzheimer Disease/diagnostic imaging
SELECTION OF CITATIONS
SEARCH DETAIL